article·Cancer Cell·May 18, 2017Closed access

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations

YZYiqun ZhangPKPatrick Kwok‐Shing NgMHMelanie H. KucherlapatiFCFengju ChenYLYuexin Liu

Baylor College of Medicine · The University of Texas MD Anderson Cancer Center · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

656
total citations
FWCI
24.75
Percentile
100%
References
46
Citations per year

Authors

42
  • YZ
    Yiqun Zhang

    Baylor College of Medicine

  • PK
    Patrick Kwok‐Shing Ng

    The University of Texas MD Anderson Cancer Center

  • MH
    Melanie H. Kucherlapati

    Harvard University, Brigham and Women's Hospital

  • FC
    Fengju Chen

    Baylor College of Medicine

  • YL
    Yuexin Liu

    The University of Texas MD Anderson Cancer Center

Topics & keywords

Topics
  • Primary topicPI3K/AKT/mTOR signaling in cancer100%
  • CRISPR and Genetic Engineering99%
  • Cancer Genomics and Diagnostics98%
Keywords
  • PI3K/AKT/mTOR pathway
  • PTEN
  • Biology
  • Protein kinase B
  • STK11
  • Cancer research
  • Genetics
  • Mutation
No related works found for this paper.

Funding

  • BC
    Breast Cancer Research Foundation
  • P
    Pfizer
  • A
    AstraZeneca
  • CP
    Cancer Prevention and Research Institute of Texas
    Awards: 5P50CA098258, RP120713 C2, 5U01CA168394
  • A
    AbbVie
  • UO
    University of Arizona Cancer Center
    Award: P30CA016672
  • I
    Illumina
  • NI
    National Institutes of Health
    Awards: CA175486, 2P50CA101942-11A1, 5P01CA120964, CA209851, P30CA125123, U24CA143883, 1R21CA191687